Discussion This systematic review highlights the multifaceted therapeutic potential of GLP-1 RAs in patients with PD, particularly through their neuroprotective, metabolic, and symptomatic effects
If Zepbound Is Covered for OSA If your plan covers Zepbound for the OSA indication, here's what to expect for costs in 2026: 2026 Part D Out-of-Pocket Cap: Medicare Part D has a $2,100 annual out-of-pocket maximum for 2026 (up from $2,000 in 2025)
So, Are GLP-1s Ever a Good Option
If you are relatively lean and trying to shed the last few pounds of stubborn fat, the marginal benefit might be noticeable, though still unproven in rigorous clinical settings
Never stop Ozempic without consulting your healthcare provider, who can help you transition safely off the medication and explore alternative options if needed
This effect is transient (lasting 24 hours post-injection) and dose-dependent